Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Jagsonpal Pharmaceuticals Limited Call Transcript 2024

Oct 16, 2024

62844_rns_2024-10-16_e7cd1d51-0d12-4e56-ac59-298077f1b058.pdf

Call Transcript

Open in viewer

Opens in your device viewer

A CSR Initiative

==> picture [50 x 28] intentionally omitted <==

JAGSONPAL PHARMACEUTICALS LIMITED

==> picture [39 x 48] intentionally omitted <==

Corporate Office: Nimai Tower, 3[rd] Floor, Plot No. 412-415, Phase-IV, Udyog Vihar, Gurugram -122015, Haryana (India)

October 16, 2024

The Department of Corporate Services- Listing
BSE Ltd,
Phiroze Jeejeebhoy Towers,
Dalal Street
Mumbai-400 001
Scrip Code: 507789
The Department of Corporate Services- Listing
National Stock Exchange of India Ltd
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex, Bandra
(E) Mumbai – 400 051Symbol:
JAGSNPHARM

Subject: Intimation of Analysts/ Investors Conference call

Dear Sir/ Madam,

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,we wish to inform you that the Company, as a part of its investors engagement activities, has scheduled a conference call with the Analysts / Investors on Thursday, October 24, 2024, to discuss its Q2 FY25 & H1 FY25 financial results. The Conference call details is attached as Annexure I.

We request you to take the above on record.

Thanking you,

For Jagsonpal Pharmaceuticals Limited

ABHISHEK Digitally signed by ABHISHEK JOSHI JOSHI Date: 2024.10.16 19:20:04 +05'30'

Abhishek Joshi

Company Secretary & Compliance Officer

Ph.: +91 124 4406710; E-mail: [email protected]; Website: www.jagsonpal.com CIN NO. L74899DL1978PLC009181 Regd. Office: T-210 J, Shahpur Jat, New Delhi - 110049 (India)

==> picture [78 x 112] intentionally omitted <==

==> picture [133 x 90] intentionally omitted <==

Jagsonpal Pharmaceuticals Limited Q2FY25 Earnings Conference Call

Hosted by Go India Advisors

==> picture [114 x 139] intentionally omitted <==

Manish Gupta Managing Director

==> picture [123 x 139] intentionally omitted <==

Ashish Lakhotia

Chief Financial Officer

==> picture [32 x 35] intentionally omitted <==

Thursday, October 24, 2024 IST 11:00 AM ONWARDS

Call in Details: Pre-register to avoid wait time, join with Diamond Pass.

Registration link: CLICK HERE

Dial in Numbers: Please dial-in at least 5-10 minutes prior to the conference call schedule to ensure that you are connected to the call on time

==> picture [34 x 34] intentionally omitted <==

Universal Dial-In Number

+91 22 6280 1557, +91 22 7115 8383

For further information, kindly contact:

Hashika Mutreja Sheetal Khanduja [email protected] [email protected]